Farallon Capital Management LLC

All filings by Farallon Capital Management LLC on record concern Nexvet Biopharma plc. Over a trading history stretching from 24 February 2016 to 31 July 2017, the count stands at 32 filings.

Purchases make up the whole of the open-market record (24 purchases, €1.3M). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.

The median purchase comes to €21k. 24 out of 24 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The newest entry dates from 2 August 2017: a transaction of €4.7M, in Nexvet Biopharma plc. The last purchase on record was published on 26 February 2016, which is 3,892 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.